Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Revenue of $97323.0 for Q3 2021, down 92.09% year-over-year from $1.2 million in Q3 2020, and down 28.73% quarter-over-quarter from $136558.0 in Q2 2021.
Corbus Pharmaceuticals Holdings (CRBP) Revenue (2015 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' Revenue history runs 7 years deep, the most recent figure standing at $97323.0 for Q3 2021.
- In Q3 2021, Revenue fell 92.09% year-over-year to $97323.0; the TTM figure through Jun 2022 stood at $97323.0 (down 97.39% YoY), while the FY2021 annual figure was $881705.0, down 82.37% from the prior year.
- Revenue for Q3 2021 stood at $97323.0, down from $136558.0 in the prior quarter.
- The five-year high for Revenue was $29.1 million in Q2 2019, with the low at -$28.6 million in Q4 2019.
- The 5-year median for Revenue is $1.0 million (2018), against an average of $1.0 million.
- Peak annual rise in Revenue reached 3308.27% in 2019, while the deepest fall reached 1582.38% in 2019.
- Corbus Pharmaceuticals Holdings' Revenue stood at $796312.0 in 2017, then surged by 142.03% to $1.9 million in 2018, then slumped by 1582.38% to -$28.6 million in 2019, then soared by 106.02% to $1.7 million in 2020, then tumbled by 94.34% to $97323.0 in 2021.
- Business Quant data shows CRBP's Revenue at $97323.0 in Q3 2021, $136558.0 in Q2 2021, and $647824.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 121.72 Mn | -41.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 97,323.00 |
| Jun 30, 2021 | 136,558.00 |
| Mar 31, 2021 | 647,824.00 |
| Dec 31, 2020 | 1.72 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | 286,346.00 |
| Mar 31, 2020 | 1.76 Mn |
| Dec 31, 2019 | -28.57 Mn |
| Sep 30, 2019 | 2.59 Mn |
| Jun 30, 2019 | 29.09 Mn |
| Mar 31, 2019 | 1.89 Mn |
| Dec 31, 2018 | 1.93 Mn |
| Sep 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 853,646.00 |
| Mar 31, 2018 | 950,442.00 |
| Sep 30, 2017 | 796,312.00 |
| Jun 30, 2017 | 350,186.00 |
| Mar 31, 2017 | 1.29 Mn |
| Sep 30, 2016 | 742,558.00 |
| Jun 30, 2016 | 396,598.00 |